Ligand Pharmaceuticals Inc (NASDAQ:LGND)
| 70.46 Delayed Data As of Jan 27 |  0.00 / 0.00%Today’s Change | 45.25 Today|||52-Week Range 83.95 | +5.47% Year-to-Date |
Latest LGND News | Press Releases
No recent news for Ligand Pharmaceuticals Inc.
Today’s Trading
| Previous close | 70.46 |
| Today’s open | 70.03 |
| Day’s range | 70.03 - 71.53 |
| Volume | 2,451 |
| Average volume (3 months) | 175,049 |
| Market cap | $1.2B |
Data as of 3:59pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -28.13% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +48.66% |
| P/E ratio | NM |
| Price/Sales | 9.61 |
| Price/Book | 1.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACRSAclaris Therapeutics... | +0.68 | +4.04% |
| TAROTaro Pharmaceutical ... | +0.16 | +0.52% |
| CRNXCrinetics Pharmaceut... | +0.43 | +2.15% |
| ENTAEnanta Pharmaceutica... | +0.53 | +1.03% |
Data as of 3:59pm ET, 01/27/2023
Financials
| Next reporting date | February 23, 2023 |
| EPS forecast (this quarter) | $0.78 |
| Annual revenue (last year) | $277.1M |
| Annual profit (last year) | $57.1M |
| Net profit margin | 20.62% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
